Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease

Author： Van Kampen J. Robertson H. Hagg T. Drobitch R.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.184, Iss.1, 2003-11, pp. : 521-529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antiparkinsonian Action of a Opioid Agonist in Rodent and Primate Models of Parkinson's Disease

By Hille C.J. Fox S.H. Maneuf Y.P. Crossman A.R. Brotchie J.M.

Experimental Neurology, Vol. 172, Iss. 1, 2001-11 ,pp. : 189-198

Elsevier

Access to resources Recommend Favorite

Neuroprotective Therapy for Parkinson's Disease

By Koller W.C.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Neurotoxicological and Neuroprotective Elements in Parkinson's Disease

By Kostrzewa Richard M. Segura-Aguilar Juan

Neurotoxicity Research, Vol. 4, Iss. 2, 2002-01 ,pp. : 83-86

Springer Publishing Company

Access to resources Recommend Favorite

Multifunctional neuroprotective–neurorescue drugs for Parkinson’s disease

By Van der Schyf Cornelis J Geldenhuys Werner J Youdim Moussa BH

Future Neurology, Vol. 2, Iss. 4, 2007-07 ,pp. : 411-423

Future Medicine

Access to resources Recommend Favorite

Primate models of Parkinson's disease

By Collier T.J. Steece-Collier K. Kordower J.H.

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 258-262

Elsevier

Access to resources Recommend Favorite